GB1155730A - Method of Producing Antitoxins - Google Patents
Method of Producing AntitoxinsInfo
- Publication number
- GB1155730A GB1155730A GB4760166A GB4760166A GB1155730A GB 1155730 A GB1155730 A GB 1155730A GB 4760166 A GB4760166 A GB 4760166A GB 4760166 A GB4760166 A GB 4760166A GB 1155730 A GB1155730 A GB 1155730A
- Authority
- GB
- United Kingdom
- Prior art keywords
- milk
- protein
- remaining
- water
- antitoxins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
1,155,730. Antitoxins. IMMUNE MILK CO. OF AMERICA, Inc. 24 Oct., 1966 [24 Oct., 1965], No. 47601/66. Heading A5B. Antitoxins are produced through the milk systems of female members of the equine, bovine, canine, porcine, hircine and camel species by a method including the steps of Iryper-immunizing said animal with a commercial toxoid, collecting the milk from the hyper-immunized animal, removing casein from the milk, concentrating the protein from the remaining milk serium of filtration, precipitation and centrifuging, emulsifying the concentrated residue with water, removing salt from the emulsion by dialysis, and collecting and freeze drying the remaining protein antitoxin. The collected milk may be diluted with sterile distilled water, the centrifuged sediment recovered in a sterile container, filtered, refrigerated and collected prior to emulsification with water. The animals may be given 5 cc. of commercial toxoid e.g. tetanus toxoid, at weekly intervals for a total of 8 weeks to produce hyper-immunization. Concentrated rennet may be thoroughly mixed with the diluted milk heated to about 100‹F. in the proportion of 5 parts by volume per 100,000 parts of dilute milk, said mixture is cooled to about 80‹F., permitted to coagulate for about one hour, agitated to break up the clots which have formed, and milk serum is withdrawn from the coagulated casein. Protein is precipitated from the milk serum by filtering the serum through multiple layers of cheese-cloth adjusting the pH to 6.8, adding ammonium sulphate, mixing thoroughly and holding: at about 40‹F.. for about 12 hours, siphoning off and discarding the clear supernatant liquid centrifuging at 20,000g the remaining precipitated protein solution, discarding the clear supernatant solution, placing the sediment on filter paper to absorb the remaining fluid, refrigerating for about 12 hours at -20‹F., recovering from the filter paper, emulsifying with water in the proportion of 10 gms of protein to 5 cc. of water, dialyzing against sterile distilled water for about 72 hours and freeze drying the remaining protein antitoxin. Antitoxins which may be produced by the above method include tetanus, diphtheria, staphylococcus, shigilla and botulinum, snake venom and toxins produced by micro-organisms such as bacteria e.g. Rickettsia, viruses, moulds and fungi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50502365A | 1965-10-24 | 1965-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1155730A true GB1155730A (en) | 1969-06-18 |
Family
ID=24008683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4760166A Expired GB1155730A (en) | 1965-10-24 | 1966-10-24 | Method of Producing Antitoxins |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5136326B1 (en) |
CH (1) | CH488013A (en) |
DE (1) | DE1617538C3 (en) |
GB (1) | GB1155730A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5314521U (en) * | 1976-07-20 | 1978-02-07 | ||
SE448344B (en) * | 1978-02-06 | 1987-02-16 | Stolle Res & Dev | ANTIBODY FOR TREATMENT OF REUMATOID ARTHRIT AND SETTING TO MAKE IT |
-
1966
- 1966-10-24 JP JP7015466A patent/JPS5136326B1/ja active Pending
- 1966-10-24 DE DE1966J0032087 patent/DE1617538C3/en not_active Expired
- 1966-10-24 CH CH1537366A patent/CH488013A/en not_active IP Right Cessation
- 1966-10-24 GB GB4760166A patent/GB1155730A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CH488013A (en) | 1970-03-31 |
DE1617538A1 (en) | 1971-04-08 |
JPS5136326B1 (en) | 1976-10-07 |
DE1617538C3 (en) | 1979-10-04 |
DE1617538B2 (en) | 1979-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5707678A (en) | Method for microfiltration of milk or colostral whey | |
US4402938A (en) | Food and the method of extracting the same from colostrum and milk | |
US4051235A (en) | Method of preparing bovine colostrum for use in treating livestock | |
CN101501059B (en) | Method for extraction of one or several proteins present in milk | |
KR101645957B1 (en) | Process for producing milk fractions rich in secretory immunoglobulins | |
ES468808A1 (en) | Process for the production of a protein concentrate containing immunological factors of lactic origin | |
US20050220953A1 (en) | Process of isolating lactoferrin | |
US5670196A (en) | Method for microfiltration of milk or colostral whey | |
US6426109B1 (en) | Method of treating colostrum | |
Seibert | The chemical composition of the active principle of tuberculin. XI. An improved and simplified method for making a standard undenatured tuberculin of any desired strength and a method of chemical assay. | |
IE861576L (en) | Separating alpha-lactalbumin from whey proteins dna segment conferring high frequency transduction of¹recombinant dna vectors | |
GB1155730A (en) | Method of Producing Antitoxins | |
JP3929085B2 (en) | Method for producing ganglioside-rich composition | |
Wang et al. | Manufacturing technologies of whey protein products | |
EP2730170A1 (en) | Food compositions free of allergens | |
US6521277B1 (en) | Process for the preparation of colostrum | |
Gesan-Guiziou | Integrated membrane operations in whey processing | |
Osborne | THE PROTEINS OF COW'S MILK.* BY THOMAS B. OSBORNE AND ALFRED J. WAKEMAN. WITH THE COOPERATION OF CHARLES S. LEAVENWORTH AND OWEN L. NOLAN. | |
Wright et al. | Purification of recombinant proteins from sheep's milk | |
EP1041081A2 (en) | Method of manufacturing composition with high ganglioside content | |
GB2132466A (en) | Whey product and method for obtaining same | |
US2123198A (en) | Treatment of antitoxins and the like | |
JPH09110896A (en) | Purification of component 3 of cow milk proteose peptone | |
Blackwell | Potential transmission of foot-and-mouth disease in whey constituents | |
RU1417244C (en) | Method of preparing of substance recovering prostate gland function |